KEROS THERAPEUTICS INC. - COMMON STOCK

14.56

10-January-25 16:45:00

15 minutes delayed

Stocks

-0.33

-2.22%

Today's range

13.96 - 14.69

ISIN

N/A

Source

NASDAQ

Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association

12 May 2021 16:01:00 By Nasdaq GlobeNewswire
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

06 May 2021 16:01:02 By Nasdaq GlobeNewswire
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

25 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference

05 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference

02 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 Feb 2021 08:00:01 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.